Sanofi sarilumab
Tuesday 01 January 2013
Professor De Smet became the coordinator of the European study sarilumab for uveitis which do not adequately respond to the usual therapies. Sarilumab is a monoclonal antibody directed against the interleukin (IL)-6 receptor, a receptor involved in the inflammatory process.